Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Myovant Sciences Ltd. (MYOV)

20.03   -0.12 (-0.6%) 07-02 16:00
Open: 20.32 Pre. Close: 20.15
High: 20.4448 Low: 19.8309
Volume: 561,564 Market Cap: 1,800M
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was founded in 2016 and is based in London, the United Kingdom. As of December 27, 2019, Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.479 - 20.596 20.596 - 20.722
Low: 19.506 - 19.634 19.634 - 19.773
Close: 19.788 - 20.011 20.011 - 20.254

Technical analysis

as of: 2020-07-02 4:32:41 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 25.77     One year: 30.10
Support: Support1: 15.78    Support2: 11.89
Resistance: Resistance1: 22.07    Resistance2: 25.77
Pivot: 18.72
Moving Average: MA(5): 20.10     MA(20): 18.25
MA(100): 12.27     MA(250): 10.68
MACD: MACD(12,26): 1.60     Signal(9): 1.56
Stochastic oscillator: %K(14,3): 70.38     %D(3): 68.76
RSI: RSI(14): 63.81
52-week: High: 22.07  Low: 4.14  Change(%): 139.9
Average Vol(K): 3-Month: 137211  10-Days: 177734

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MYOV has closed below upper band by 30.0%. Bollinger Bands are 62.8% wider than normal. The large width of the bands suggest high volatility as compared to MYOV's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 30 Jun 2020
What's Myovant Sciences Ltd (MYOV) Stock Outlook? - InvestorsObserver

Tue, 30 Jun 2020, Evidation Health, Movember, and Myovant Sciences Launch Forward Momentum Coalition to Increase Diversity in Research and Develop New Digital Resources for Men with Prostate Cancer - GlobeNewswire

Tue, 30 Jun 2020
Why Buy stock in Myovant Sciences Ltd. (MYOV)? - Marketing Sentinel

Fri, 26 Jun 2020
Do Analysts Expect Myovant Sciences Ltd (MYOV) Stock to Rise Next Year? - InvestorsObserver

Wed, 24 Jun 2020
Myovant Sciences Ltd. (NYSE:MYOV) Stock is Soaring, Here is Why - The Oracle Dispatch

Wed, 24 Jun 2020
Is Myovant Sciences Ltd (MYOV) Stock a Great Value? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 90
Shares Float (M) 35
% Held by Insiders 59.91
% Held by Institutions 37.60
Shares Short (K) 3,010
Shares Short P. Month (K) 3,190

Stock Financials

EPS -3.370
EPS Est This Year -1.440
EPS Est Next Year -1.200
Book Value (p.s.) -1.210
Profit Margin
Operating Margin
Return on Assets (ttm) -117.8
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.906
Qtrly Earnings Growth
Operating Cash Flow (M) -221
Levered Free Cash Flow (M) -109

Stock Valuations

PE Ratio -5.94
PEG Ratio
Price to Book value -16.55
Price to Sales
Price to Cash Flow -8.14

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.